Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
Jennifer Caudle, DO
Patricia A. Mangan, RN, MSN, APRN-BC
Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer
Elizabeth Montgomery, MD
John L. Marshall, MD
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
Jacob R. Bledsoe, MD
WHIM Syndrome (A Chronic Neutropenic Disorder): Uncouple the Complex for HCPs and Patients
Jolan Walter, MD, PHD
Teresa K. Tarrant, MD
Peter E. Newburger, MD
WHIM Syndrome Management: The First FDA Approval for Patients
WHIM Syndrome Treatment: We Can Do Better!
WHIM Syndrome: A Chronic Neutropenic Disorder
Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints
Hussein Tawbi, MD, PhD
Patient Case: Tailoring First-Line Treatment for a Patient With Metastatic Melanoma and Impaired Performance Status
Future Directions: Targeting LAG-3 in Melanoma Treatment
Leveraging LAG-3: Innovative Immunotherapy Combinations for First-Line Metastatic Melanoma Treatment
Allison Betof Warner, MD, PhD
Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Combination Regimens
Yelena Janjigian, MD
Samuel J. Klempner, MD
Integrating Clinical Insights: Key G/GEJ Cancer Data Analyzed from the San Diego Oncology Conference
A Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Efficacy Data for Bispecific Antibodies in RRMM
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.